After Trap And Disproportionate Assets, Now Third Case Registered Against Divya Mittal

Jaipur: The troubles of SOG’s suspended ASP Divya Mittal now seem to be increasing once again. Now ACB has registered a new case against him. This case is related to taking a bribe of Rs 1 crore in exchange for laxity in the investigation of two cases registered in relation to drugs and not arresting the accused. In the new case registered, it is alleged that Divya Mittal had taken a bribe of Rs 1 crore from Sanjay Nandwani of Dehradun (Uttarakhand) in a hotel in Pushkar. This case has been registered on the report of the then Deputy Superintendent Mangilal, who investigated the entire matter.

In fact, SOG’s ASP Divya Mittal was arrested by ACB in January this year after verifying the complaint of complainant Vikas Aggarwal and registered a case. After this action, ACB searched his premises and found out that he had assets many times his income. On this, ACB had filed a case of disproportionate assets against him. Now this new case has been registered against Divya Mittal after the investigation confirmed that she took a bribe of Rs 1 crore in exchange for laxity in the investigation of two drug related cases. Sanjay Nandwani, who gave bribes, has also been accused in this case.

: According to the FIR registered by ACB, Divya Mittal was arrested by ACB in January this year in a bribery case. During the investigation, complainant Vikas Aggarwal gave audio and video as evidence to ACB. It was revealed that Divya Mittal had taken a bribe of Rs 1 crore from his brother Sanjay Nandwani in exchange for relaxation in the investigation of two drug cases registered against drug businessman Sunil Nandwani. This amount was taken from a hotel in Pushkar.

ACB had sent the evidence provided by the complainant to FSL for investigation. Where investigation revealed that no tampering had been done. In such a situation, after the investigation report came, ACB has registered another case against Divya Mittal. This case has been registered on the report of the then Deputy Superintendent Mangilal, who investigated this entire matter.

Let us tell you that three cases were registered against a drug dealer named Sunil Nandwani regarding drugs in Ajmer. The investigation of these three cases registered in different police stations of Ajmer was handed over to SOG ASP Divya Mittal. It is alleged that in one of these cases, she had arrested Sunil Nandwani, while in two other cases, Divya Mittal had taken a bribe of Rs 1 crore from Sunil Nandwani’s brother Sanjay Nandwani in exchange for not arresting her.

Related Posts

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines